Neuroscientific Biopharmaceuticals Ltd Cash Flow Reinvestment Rate

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd cash flow reinvestment rate. Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting AU$1.82K (capex AU$1.82K ) from operating cash flow of AU$1.62 Million. Explore Neuroscientific Biopharmaceuticals Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.82K

Capex + Investments

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Cash Flow Reinvestment Rate of Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Cash flow reinvestment rate of Neuroscientific Biopharmaceuticals Ltd from 2024 to 2024. Historical reinvestment intensity for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Explore Neuroscientific Biopharmaceuticals Ltd (NSB) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Neuroscientific Biopharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2024–2024)

Neuroscientific Biopharmaceuticals Ltd cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Neuroscientific Biopharmaceuticals Ltd. For the full cash flow conversion analysis, see Neuroscientific Biopharmaceuticals Ltd cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2024	0.08x	AU$3.63K	AU$44.25K	AU$1.81K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow